NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024
Buyer: NHS England
- Published
- 26 February 2024
- Estimated value
- £74
- Place of performance
- UK
- Procedure
- Open procedure
- Notice number
- 006097-2024
- Reference
- ocds-h6vhtk-040e74
- Official source
- Official source
CPV codes
- 33600000Pharmaceutical products
Description
Project Title: NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024 Offer reference number: CM/PHR/22/5678 CM/PHR/22/5678/01 - NHS Framework for NORTH OF ENGLAND Branded Medicines - Tranche B. Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/02 - NHS Framework for NORTH OF ENGLAND Branded Medicines (to transition to Tranche B) Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5678/03 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines - Tranche A. Period of framework: 1 March 2024 to 31 August 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months CM/PHR/22/5678/04 - NHS Framework for MIDLANDS AND EAST of England Branded Medicines (to transition to Tranche B). Period of framework: 1 March 2024 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or…
Lots (4)
| Lot | Description | CPV code | Amount |
|---|---|---|---|
| 1 | CM/PHR/22/5678/01 | 33600000 Pharmaceutical products | — |
| 2 | CM/PHR/22/5678/02 | 33600000 Pharmaceutical products | — |
| 3 | CM/PHR/22/5678/03 | 33600000 Pharmaceutical products | — |
| 4 | CM/PHR/22/5678/04 | 33600000 Pharmaceutical products | — |
Awards
| Awarded to | Amount | Date |
|---|---|---|
| Neon Healthcare Ltd | — | — |
| Pfizer Ltd | — | — |
| Bayer Plc | — | — |
| Sandoz Ltd | — | — |
| Mylan | — | — |
| Eli Lilly and Company Ltd | — | — |
| Roche Products Ltd | — | — |
| Ipsen | — | — |
| Novo Nordisk | — | — |
| Biogen | — | — |
Official publications
- FTS · 006097-2024 · 26 February 2024
Other tenders from NHS England
- Enhanced Mental Health Pathway
- Enhanced Mental Health Pathway
- NHS Vaccination and Immunisation Services
- NHS Vaccination and Immunisation Services
- Fertility service for preservation and use of reproductive tissue for service users who cannot store mature eggs/sperm who are at high/very…
- Integrated Healthcare Services at HMP Welland Oaks
- Tier 4 Lead Provider for CAMHS
- Onasemnogene Abeparvovec Intravenous (Zolgensma®) Service & Onasemnogene Abeparvovec Intrathecal (OAV101 IT) Service
- Black Country Covid-19 Targeted Outreach Intervention: Mobile vaccination provision
- Covid Vaccinations to Nottinghamshire Housebound Patients
Frequently asked questions
- What is the estimated value of this tender?
- The estimated value published by the buyer is £74.
- Who is the buyer of this tender?
- The contracting authority is NHS England (United Kingdom).
- How can I bid for public tenders in the United Kingdom?
- Bids are submitted through the official public procurement portal in the United Kingdom. El Vínculo helps you find tenders and analyse their documents; submission always happens at the official source.
Create a free account and receive new public tenders published in the United Kingdom that match your business, every day.